Successful Treatment of a Patient with Drug-Refractory Rheumatoid Arthritis-Associated Interstitial Lung Disease with Upadacitinib: A Case Report

Insufficient evidence exists regarding the efficacy of Janus kinase inhibitors (JAKis), a class of targeted synthetic disease-modifying anti-rheumatic drugs (tsDMARDs), in the treatment of rheumatoid arthritis (RA)-associated interstitial lung disease (ILD). Herein, we present a case of RA-ILD refra...

Descripción completa

Detalles Bibliográficos
Autores principales: Nishii, Yuuya, Okamoto, Masaki, Zaizen, Yoshiaki, Kojima, Takashi, Nouno, Takashi, Naitou-Nishida, Yoshiko, Matsuo, Norikazu, Takeoka, Hiroaki, Ishida, Motoko, Nakamura, Masataka, Masuda, Toru, Tanaka, Takafumi, Miyamura, Tomoya, Hoshino, Tomoaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10673512/
https://www.ncbi.nlm.nih.gov/pubmed/38004009
http://dx.doi.org/10.3390/medicina59111960

Ejemplares similares

Ejemplares similares